Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
16.11%
operating margin TTM
24.47%
revenue TTM
9.76 Billion
revenue per share TTM
66.55$
valuation ratios | |
|---|---|
| pe ratio | 16.90 |
| peg ratio | 3.48 |
| price to book ratio | 1.49 |
| price to sales ratio | 2.72 |
| enterprise value multiple | 7.01 |
| price fair value | 1.49 |
profitability ratios | |
|---|---|
| gross profit margin | 70.12% |
| operating profit margin | 24.47% |
| pretax profit margin | 19.07% |
| net profit margin | 16.11% |
| return on assets | 5.51% |
| return on equity | 9.25% |
| return on capital employed | 9.43% |
liquidity ratios | |
|---|---|
| current ratio | 2.72 |
| quick ratio | 2.04 |
| cash ratio | 1.17 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 270.23 |
| operating cycle | 337.85 |
| days of payables outstanding | 50.53 |
| cash conversion cycle | 287.33 |
| receivables turnover | 5.40 |
| payables turnover | 7.22 |
| inventory turnover | 1.35 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.23 |
| debt equity ratio | 0.36 |
| long term debt to capitalization | 0.26 |
| total debt to capitalization | 0.27 |
| interest coverage | 9.40 |
| cash flow to debt ratio | 0.37 |
cash flow ratios | |
|---|---|
| free cash flow per share | 15.53 |
| cash per share | 27.02 |
| operating cash flow per share | 16.74 |
| free cash flow operating cash flow ratio | 0.93 |
| cash flow coverage ratios | 0.37 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 13.93 |
Frequently Asked Questions
When was the last time Biogen Inc. (NASDAQ:BIIB) reported earnings?
Biogen Inc. (BIIB) published its most recent earnings results on 30-10-2025.
What is Biogen Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Biogen Inc. (NASDAQ:BIIB)'s trailing twelve months ROE is 9.25%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Biogen Inc. (BIIB) currently has a ROA of 5.51%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIIB's net profit margin stand at?
BIIB reported a profit margin of 16.11% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIIB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.72 in the most recent quarter. The quick ratio stood at 2.04, with a Debt/Eq ratio of 0.36.